Is Hydroxyurea Treatment Changing the Life of Children with Sickle Cell Disease?
Background: Sickle cell disease (SCD) is a prevalent hemoglobinopathy involving sickled hemoglobin that causes multiorgan disease due to chronic recurrent vaso-occlusion and hemolysis. Fetal hemoglobin (HbF) being present showed reduction in disease severity, owing to which hydroxyurea has gained si...
Saved in:
| Main Authors: | Mohammed Ali Al Sabbah, Mahmoud Radaideh, Shafeeka Mohammed Saleh, Sura Ahmed Al-Doory, Amal Mahmoud Abdalqader, Fatima Farid Mir, Aya Mohammed |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Knowledge E
2023-07-01
|
| Series: | Dubai Medical Journal |
| Subjects: | |
| Online Access: | https://beta.karger.com/Article/FullText/531257 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
An In vitro investigation of Lactobacillus plantarum F4 Strain’s Anti-sickling and Fetal Hemoglobin Inducing Effects on Sickled Erythrocytes
by: Firdosh Shah, et al.
Published: (2025-03-01) -
Incidence of avascular necrosis in patients with sickle cell anemia received hydroxyurea and blood transfusion: a comparative study
by: Asmaa Hassan Khudhair, et al.
Published: (2024-12-01) -
Influence of hydroxyurea on tubular phosphate handling in sickle cell nephropathy
by: Gabriela Araujo de Abreu, et al.
Published: (2024-11-01) -
Optimization of hydroxyurea in sickle cell disease in Brazil
by: Clarisse Lobo, et al.
Published: (2025-04-01) -
Clinical and laboratory features of Hemoglobin La Desirade variant in association with sickle cell and alpha thalassemia genes
by: Salam Alkindi, et al.
Published: (2021-01-01)